Boothbay Fund Management »

Caris Life Sciences shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $445k 17k 26.98
2025-06-30 $451k 17k 26.72

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Caris Life Sciences

J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
PointState Capital
Millennium Management
Neuberger Berman Group
OrbiMed Advisors
BlackRock
UBS Group
Point72 Asset Management
Ameriprise Financial
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences